HM PAYSON & CO - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
HM PAYSON & CO ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,056
-22.4%
650.0%0.00%
Q2 2023$2,651
+9.4%
650.0%0.00%
Q1 2023$2,423
+6.8%
650.0%0.00%
Q4 2022$2,268
-43.3%
650.0%0.00%
Q3 2022$4,000
+33.3%
650.0%0.00%
Q2 2022$3,000
-40.0%
650.0%0.00%
Q1 2022$5,000
-37.5%
650.0%0.00%
Q4 2021$8,000
-11.1%
650.0%0.00%
Q3 2021$9,000650.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders